BioCurex, Inc.(fka BOCX)

[HALF FULL GLASS]

"Pending approval of our patent, we have delayed publishing results in scientific journals since this would require us to supply extensive information so the studies can be reproduced by other scientists. Publishing certain critical information prior to receiving the approval for our patent would constitute 'prior art' that could interfere with the claim for a patent."

It is a shame but a fact of life, IMO this step of publishing the current Recaf results and then allowing for reproducible lab experiments proving Recaf, has to happen prior to going mainstream to CNN etc.

Without this, there are many persons or companies that will shadow the current results with black clouds. This effect would place doubt in the publics eye and would keep us spinning our wheels.

The (easy to use) ELISA test should now allow the replication in a short amount of time.

The Doctor is doing it right. Yes it is going at a turtle speed but remember the race between the turtle and the rabbit